Ethical considerations
The present study was approved by the Ethics Committee of Zanjan University of Medical Sciences [IR.ZUMS.REC.1399.158]. Written informed consent was obtained from all participant. Patients entered the study with their full awareness and willingness. Patients could withdraw from the study at any time. The medicine used in the present study has potentially no serious side effects. No prescription charges were obtained from patients.